Related Experiment Video
Updated: Jun 8, 2025

07:33
Robotic Spleen-Preserving Distal Pancreatectomy: The Warshaw and Kimura Techniques
Published on: July 26, 2024
1.5K
Noninferiority Randomized Clinical Trial: KIM Sling With Reusable Trocars Versus TVT Exact Sling
Samantha L Margulies1, Anna E Osment2, Adele Bernard2
1From the Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill, Chapel Hill, NC.
Urogynecology (Philadelphia, Pa.)
|November 8, 2024
Summary
The Neomedic Knotless Incontinence Mesh (KIM) sling was not found to be noninferior to the TVT Exact sling for treating stress urinary incontinence at six weeks. Further outcomes will be assessed at six months and one year.
Area of Science:
- Urology
- Gynecology
- Medical Devices
Background:
- Stress urinary incontinence (SUI) affects many women, with midurethral slings being a common treatment.
- The Neomedic Knotless Incontinence Mesh (KIM) sling offers potential environmental benefits due to sterilizable trocars.
- Comparative data on the efficacy of the KIM sling versus established slings are limited.
Purpose of the Study:
- To compare the efficacy of the retropubic KIM sling with the Gynecare TVT Exact sling in women with SUI.
- To determine if the KIM sling is noninferior to the TVT Exact sling based on subjective success at six weeks.
Main Methods:
- A single-center, randomized noninferiority trial was conducted.
- 147 women with SUI were randomized to either the KIM sling or the TVT Exact sling.
- Primary outcome was subjective success at 6 weeks, defined by a composite score and no SUI retreatment.
Main Results:
- Subjective success rates at 6 weeks were 68.5% for the KIM sling and 83.3% for the TVT Exact sling.
- The KIM sling did not meet the noninferiority margin compared to the TVT Exact sling (risk difference 14.8%).
- No significant differences were observed in secondary outcomes, including urinary retention and mesh complications.
Conclusions:
- The retropubic KIM sling is not noninferior to the TVT Exact sling for treating SUI at six weeks.
- The clinical trial is ongoing to evaluate longer-term outcomes at six months and one year.
- The study highlights the need for further comparative data on novel incontinence mesh devices.

